Curie Oncology

Curie Oncology Our caring doctors and nurses at Curie Oncology offer our patients prompt and accurate detection, diagnosis, treatment, support and follow up care.

We provide advance cancer care in a holistic and supportive environment for the patient and their family.

🎉 Happy 60th National Day, Singapore! 🇸🇬Sixty years of growth, unity, and dreams fulfilled. Here’s to our people, our pr...
09/08/2025

🎉 Happy 60th National Day, Singapore! 🇸🇬

Sixty years of growth, unity, and dreams fulfilled. Here’s to our people, our progress, and our future.

One nation, one heart. ❤

Dr. Yvonne Loh was part of a hybrid event connecting hematologists from Singapore and Kuala Lumpur on the topic Practica...
07/08/2025

Dr. Yvonne Loh was part of a hybrid event connecting hematologists from Singapore and Kuala Lumpur on the topic Practical Management of AML.

It was an enriching session featuring valuable insights from guest speaker Prof. Agnieszka Wierzbowska from Poland 🇵🇱, along with shared experiences from colleagues across Singapore and Malaysia.

Events like these showcase the power of collaboration 🤝 and knowledge exchange 💡 in advancing AML patient care ❤️.

💙 In conjunction with the launch of T-DXd in lung cancer, Dr Joline Lim was invited to launch events held from 24th to 2...
07/08/2025

💙 In conjunction with the launch of T-DXd in lung cancer, Dr Joline Lim was invited to launch events held from 24th to 26th July 2025 in Johor Bahru, Malacca, and Kuala Lumpur.

These sessions brought together 🩺 medical oncology specialists, 🩷 breast and lung surgeons, 🧪 pathologists, and other healthcare professionals to exchange expertise on the evolving landscape of HER2-low breast cancer treatment and HER2 mutant lung cancers.

🎯 The breast cancer program focused on highlighting the sequencing of T-DXd in the HER2-low space and its clinical implications, as well as emphasizing the shift from binary HER2 reporting to a broader HER2 spectrum, a critical advancement in breast cancer diagnostics and treatment strategy.

📢 During the sessions, Dr. Joline delivered a presentation on “Breast Cancer: Shifting Perspectives in HER2 Treatment” and joined the expert panel discussion, sharing valuable insights and exchanging best practices with our colleagues from various regions in Malaysia.

🙏 We extend our sincere appreciation to AstraZeneca for organizing this impactful program, and to all the medical professionals who contributed to meaningful discussions that will help shape the future of breast cancer management in Malaysia.

Dr. Yvonne Loh was invited to speak on “The Unmet Needs of Relapsed/Refractory DLBCL and the Role of CART Therapy.”This ...
05/08/2025

Dr. Yvonne Loh was invited to speak on “The Unmet Needs of Relapsed/Refractory DLBCL and the Role of CART Therapy.”

This engaging online session connected hematologists from BTH — the largest hematology hospital in Ho Chi Minh, serving patients across South Vietnam.

It was a vibrant exchange of knowledge, sparking meaningful discussions and strengthening our shared commitment to advancing care for patients facing this challenging disease.

Collaboration and education remain at the heart of improving patient outcomes — across borders and beyond boundaries. 🌏💉

Dr. Choo Su Pin was a speaker🎤at the Curie & UM Gastrointestinal Cancer Masterclass on 19 July 2025, organised by Dr Jen...
30/07/2025

Dr. Choo Su Pin was a speaker🎤at the Curie & UM Gastrointestinal Cancer Masterclass on 19 July 2025, organised by Dr Jenson Sow and Prof Ho Gwo Fuang from Curie Kuala Lumpur in collaboration with University of Malaya. The masterclass was held in the university grounds and had excellent attendance from many oncology trainees from KL. Dr Choo was also joined by esteemed colleagues from Malaysia as well as colleagues from National Cancer Centre Singapore and National University Cancer Institute, Singapore and South Korea.

She delivered a detailed presentation🧠on Medical Oncology, focusing on oesophagogastric junction (OGJ) and gastric cancers during the Early Upper GI Cancer session. Additionally, she participated as a panelist in the Multidisciplinary Panel Discussion💬, contributing expert insights to case-based discussions with fellow colleagues Prof Fuad Bin Ismail (Curie KL) and Dr Ramesh Gurunathan (CENGILD) and Dr Wong Wei Jin (UMMC).

Her involvement exemplifies a strong commitment to advancing multidisciplinary care🤝and improving patient outcomes in gastrointestinal oncology💪.

Is breast cancer therapy one size fits all? We are in the era of precision oncology! 🎯 Dr. Joline Lim served as a keynot...
29/07/2025

Is breast cancer therapy one size fits all? We are in the era of precision oncology! 🎯

Dr. Joline Lim served as a keynote speaker at the Medical Symposium: Crossing Frontiers in Oncology, held on Saturday, 12 July 2025.

Specialists, general practitioners, and healthcare professionals from Surabaya and beyond gathered at this symposium highlighting integrative advances in cancer diagnostics and therapy. Dr. Joline shared about how precision medicine is changing the landscape in breast cancer treatment, emphasizing the growing impact of personalized treatment in improving cancer outcomes for our patients.

The symposium was part of the Grand Opening of the Ciputra Comprehensive Cancer Centre, a joint venture between Ciputra Hospital, Singapore Medical Group (SMG), and Curie Oncology. 🎉 🎊

We are proud to have Dr. Joline represent Curie Oncology in this meaningful collaboration to advance cancer care across the region.

🎉 Grand Opening of the Ciputra Comprehensive Cancer Centre – July 12, 2025 🎉We are honoured to introduce the Ciputra Com...
25/07/2025

🎉 Grand Opening of the Ciputra Comprehensive Cancer Centre – July 12, 2025 🎉

We are honoured to introduce the Ciputra Comprehensive Cancer Centre—a strategic partnership between Ciputra Hospital Surabaya, Curie Oncology, and Singapore Medical Group.

Located on the 5th floor of Ciputra Hospital Surabaya, the centre brings together multidisciplinary teams and medical innovation to deliver integrated cancer care—from early detection to treatment.

This partnership blends best practices and compassion to provide personalised care, bringing hope and healing to Eastern Indonesia and beyond.

Dr. Yvonne was honoured to be invited to speak to a distinguished group of haematologists from Hong Kong on the topic of...
18/07/2025

Dr. Yvonne was honoured to be invited to speak to a distinguished group of haematologists from Hong Kong on the topic of Advances in the Management of Relapsed and Refractory FLT3+ AML Patients. The opportunity to share the latest clinical research, therapeutic strategies, and treatment insights in this challenging area was greatly appreciated.

It was a pleasure to reconnect with the haematologists virtually 💻, allowing for a meaningful exchange of knowledge and experience. 🤝 Such interactions foster mutual learning and collaboration, which are essential for driving progress in patient care and improving outcomes in complex hematologic malignancies.

Dr. Choo Su Pin had the honour of chairing and speaking at the 15th Asia-Pacific Primary Liver Cancer Expert Meeting (AP...
18/07/2025

Dr. Choo Su Pin had the honour of chairing and speaking at the 15th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2025), held July 11–13, 2025, in Kobe, Japan, where she delivered a lecture on "Molecular Heterogeneity and the Challenge of Predictive biomarkers in Cholangiocarcinoma"🔬🧬 during the session on Novel Strategies for CCA. Insights on the complexities of cholangiocarcinoma and the progress in determining biomarkers to optimise therapy were shared. It was a delight for Dr Choo to meet up with many old friends in the field of hepatobiliary cancers, many of whom are global experts and were part of the stellar faculty🌏.

Helping patients live not just longer, but better! 💪🏻💪🏻Peripheral numbness of the hands and feet is a common side of che...
17/07/2025

Helping patients live not just longer, but better! 💪🏻💪🏻

Peripheral numbness of the hands and feet is a common side of chemotherapy, occurring in up to 60% of patients who receive treatment for their cancers. While many other side effects of chemotherapy resolve after completion of treatment, peripheral numbness can persist in some patients, affecting patient’s long-term quality of life 🧠🖐🦶.

Curie Oncology has partnered the National University Cancer Institute, Singapore, National University Singapore, and Paxman Systems to run a clinical trial investigating the use of limb cooling❄️to decrease the risk of developing chemotherapy-induced peripheral numbness.

At the Multinational Association of Supportive Care in Cancer Annual Meeting 2025 held in Seattle, Dr Joline Lim shared the interim results of this trial, that showed that patients who underwent limb cooling concurrently while undergoing chemotherapy had lower rates of developing peripheral numbness compared to previous studies, both from physician assessment and patient reported outcomes. This technology is currently being investigated in a large randomized study in the United States, and may potentially provide a new solution for patients to prevent onset of chemotherapy-induced peripheral numbness.

We are pleased to partner and .nuhs to be part of this novel innovation, and have the opportunity to offer both scalp and limb cooling to decrease chemotherapy induced hair loss💇‍and peripheral numbness, taking steps to allow our patients to live better during their cancer journey💪💖!

🌟 Dr. Toh Chee Keong was honoured to be invited as a panellist at the 8th Cross-Strait and Three Regions Lung Cancer Aca...
27/06/2025

🌟 Dr. Toh Chee Keong was honoured to be invited as a panellist at the 8th Cross-Strait and Three Regions Lung Cancer Academic Symposium 2025 in Fuzhou, China. This is a respected forum that brings together leading lung cancer specialists from mainland China, with invitation of international panellists from Thailand, Indonesia, Malaysia and Singapore.

This symposium provides a platform for sharing the scientific research, treatment approaches, and best clinical practices in lung cancer management. During the event, Dr Toh discussed with the other panellists on the treatment and predictive biomarkers of small cell lung cancer.

🌟 We are proud to share that Dr. Choo Su Pin and Dr. Joline Lim were invited as expert speakers at the prestigious Indon...
27/06/2025

🌟 We are proud to share that Dr. Choo Su Pin and Dr. Joline Lim were invited as expert speakers at the prestigious Indonesian Society of Haematology and Medical Oncology (ISHMO) Update 2025, held from 13–15 June 2025 in Semarang, Indonesia. The event gathered oncology leaders and specialists from across the region to exchange knowledge and explore the advancements in cancer care.

👩‍⚕ Dr. Choo delivered a comprehensive session on the management of intermediate-stage hepatocellular carcinoma (HCC). She discussed evolving treatment strategies beyond conventional TACE, including patient selection, treatment sequencing, and the integration of systemic therapy and immunotherapy. Her insights were backed by the clinical data from trials such as EMERALD-1 and LEAP-012, offering fresh perspectives on how to optimize outcomes for patients with BCLC-B HCC.

👩‍⚕ Dr. Joline gave a series of talks on the emerging landscape of HER2-positive and HER2-low metastatic breast cancer, with a spotlight on the transformative role of trastuzumab deruxtecan (T-DXd). She provided an in-depth look at how the definition of HER2 expression is shifting, and how this impacts real-world treatment decisions. Her presentation underscored how continued pursuit in understanding cancer and its biology can translate to meaningful improvement in survival and quality of life for patients with advanced breast cancer.

Their presence at ISHMO Update 2025 reflects not only their continued pursuit of clinical excellence, but also our institution’s ongoing commitment to shaping the future of oncology through leadership, research, and regional collaboration.

👏 We are proud to have them represent our team on the international stage, and grateful to the Indonesian community for this opportunity to connect, interact and learn from one another.

Address

Singapore

Opening Hours

Monday 08:30 - 17:30
Tuesday 08:30 - 17:30
Wednesday 08:30 - 17:30
Thursday 08:30 - 17:30
Friday 08:30 - 17:30
Saturday 08:30 - 12:30

Telephone

+6562595538

Website

Alerts

Be the first to know and let us send you an email when Curie Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Curie Oncology:

Shortcuts

Share

Category